Processa Pharmaceuticals, Inc. (PCSA)
Modifies existing cancer drugs to make them safer and more effective.
$2.73+0.05%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-48.5%
The outlook
PCSA is trading near its 52-week lows, about 8% up from the bottom of its recent range. The stock shows a mixed trend against its moving averages, and analyst sentiment leans bearish overall. Today's movement is flat, with minimal activity.
What’s behind the score
Price trendMixed vs its moving averages
52-week range8% of the way from its 52-week low to high
Market cap
$7.6M
52-wk high
$14.25
52-wk low
$1.67
50-day avg
$2.33
200-day avg
$3.92
Trailing P/E
—